Stroke, Vol 24, 1447-1451, Copyright © 1993 by American Heart Association
M Walzl, H Lechner, B Walzl and G Schied
BACKGROUND AND PURPOSE: High fibrinogen levels have been assessed in
cerebrovascular disease with a direct relation to both plasma and whole-
blood viscosity, as well as cerebral blood flow. Heparin-induced
extracorporeal low density lipoprotein precipitation (HELP) is a new method
that safely and effectively reduces fibrinogen and plasma lipoproteins and
improves blood flow properties. METHODS: We studied 26 patients with acute
embolic stroke and 22 with multi-infarct dementia. Each received two
treatments with HELP within 8 days. Each patient had measurement of the
important blood constituents and evaluation of changes in clinical signs
and symptoms related to their cerebrovascular disease. RESULTS: Each HELP
treatment safely produced an immediate and significant reduction in
rheological measures, including fibrinogen (P < .001), whole-blood
viscosity at high and low shear rates, plasma viscosity, and red cell
transit time (P < .01 each). Total cholesterol, low density lipoprotein
(P < .0001 each), lipoprotein(a) (P < .003), and triglycerides (P
< .0001) were also reduced. The treated group in both the acute stroke
group and the multi-infarct group showed improvement relative to the
untreated control subjects in Mathew scale, Mini-Mental State Examination,
and activities of daily living test scores. These uniform improvements
persisted at least 3 days past the second HELP treatment. CONCLUSIONS:
These results support the hypothesis that the improved hemorheologic
property of blood is an important factor in clinical recovery as well as
basic neurological function.
ARTICLES
Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen
Department of Neurology, Karl-Franzens University of Graz, Austria.
This article has been cited by other articles:
![]() |
J. Berrouschot, H. Barthel, J. Koster, S. Hesse, A. Rossler, W. H. Knapp, and D. Schneider Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke : A Randomized Pilot Study Stroke, April 1, 1999; 30(4): 787 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Walzl, B. Walzl, A. Haas, and M. Walzl Heparin-Induced Extracorporeal Fibrinogen/LDL Precipitation (HELP): A Promising Regimen for the Treatment of Vascular Diseases Angiology, December 1, 1997; 48(12): 1031 - 1036. [Abstract] [PDF] |
||||
![]() |
S. Kalmijn, E.J.M. Feskens, L.J. Launer, and D. Kromhout Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly Men Stroke, December 1, 1996; 27(12): 2230 - 2235. [Abstract] [Full Text] |
||||
![]() |
A. Basile-Borgia and J. H Abel Lipoproteins in heart disease Perfusion, January 1, 1996; 11(4): 338 - 345. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |